All News

According to the investigators, Susvimo is the first and only FDA-approved treatment for wet AMD that offers as few as 2 treatments per year.

The success of the COVID-19 messenger RNA (mRNA) vaccines from Pfizer/BioNTech and Moderna has given many HIV advocates hope that a preventive mRNA vaccine is on the horizon.

Public recognition of their role has increased exponentially during the COVID-19 pandemic.

Gary Locke, former governor of Washington state, US Secretary of Commerce, and ambassador to China, discusses the World Trade Organization's TRIPS Council, which recently met to assess the elimination of IP protections for COVID-19 vaccines, diagnostics, and medical devices.

Walgreens Chief Medical Officer Kevin Ban, MD, said the Walgreens 2021-2022 Flu Index is showing high flu activity in several regions of the country.

Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.

Phase 3 ILLUMINATE showed the percentage of individuals with HIV-1 RNA levels ≥50 copies/mL for the once-a-day combination pill of doravirine/islatravir.

Officials with the FDA have approved Roche’s VENTANA PD-L1 (SP263) Assay as a diagnostic test to evaluate patients with non-small cell lung cancer (NSCLC) who are eligible to receive atezolizumab (Tecentriq, Genentech).

The drug previously received approval to treat mucosal melanoma but could be used in combination with pembrolizumab.

The immune response of all 15 serotypes in the V114 pneumococcal vaccination were higher than those in the PCV13 vaccination.

A study finds that intravenous immunoglobulin therapy is a beneficial way to combat parvovirus-induced PRCA in individuals with anemia.

World Standards Week is October 25 to 29, so Pharmacy Times interviewed Jaap Venema, PhD, EVP and CSO at USP, on some of the key shifts that have occurred in USP’s standards development during the COVID-19 pandemic.

Azo treats urinary pain, burning, urgency, and frequency associated with urinary tract infections.

Tafluprost acid, a prostaglandin analog, is a selective FP prostanoid receptor agonist that is believed to reduce intraocular pressure by increasing uveoscleral outflow.

Patients with bulimia may use different methods to get rid of calories and prevent weight gain, such as self-inducing vomiting on a regular basis.

Extravasation is defined as the inadvertent leakage of a vesicant from the vein into the surrounding tissue.

Data show 99.2% of children 5 to 11 years of age achieved a seroresponse by 1 month after completing the 2-dose vaccine series.

Other health care stakeholders can learn from pharmacists' patient-centered perspective in addressing high out-of-pocket costs.

The CDC recommends booster doses of Moderna’s COVID-19 vaccine and Johnson & Johnson’s single-shot COVID-19 vaccine for eligible individuals.

Pharmacy Times spoke with neurologist Dr. Tirisham Gyang and pharmacist Dr. Margaret Hansen about multiple sclerosis, including diagnosis, treatment options, and the role of the pharmacist in patient care.

The outmoded technology used in many pharmacies keeps pharmacists behind the scenes, tethered to slow, intermittent communication with the rest of the patient’s care team.

The investigators found that the rate of preterm birth in pregnant women who tested positive for SARS-CoV-2 was a function of the severity of infection.

After switching to Biktarvy, 91% of patients remained virologically suppressed at week 24 in a cohort study.

Simethicone is an anti-foaming agent that is taken orally to help reduce the buildup of intestinal and stomach gases that cause bloating and discomfort.

Xeljanz can be used for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and polyarticular course juvenile idiopathic arthritis.

The most common conditions that cause bladder stones are prostate gland enlargement and damaged nerves.

The approval is based on data from a phase 3 placebo-controlled trial that evaluated the efficacy and safety of dupilumab combined with standard-of-care therapy in children with uncontrolled moderate-to-severe asthma.